MBD5
Basic information
Region (hg38): 2:148021011-148516971
Links
Phenotypes
GenCC
Source:
- autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
- intellectual disability, autosomal dominant 1 (Strong), mode of inheritance: AD
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal dominant 1 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic; Ophthalmologic | 17847001; 21981781 |
ClinVar
This is a list of variants' phenotypes submitted to
- Intellectual disability, autosomal dominant 1 (52 variants)
- not provided (17 variants)
- Inborn genetic diseases (4 variants)
- Intellectual disability (2 variants)
- Autism spectrum disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MBD5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 305 | 316 | ||||
missense | 641 | 126 | 10 | 780 | ||
nonsense | 24 | 34 | ||||
start loss | 1 | |||||
frameshift | 41 | 10 | 55 | |||
inframe indel | 12 | 14 | ||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 1 | 9 | 16 | 5 | 31 | |
non coding | 57 | 21 | 82 | |||
Total | 68 | 25 | 669 | 490 | 36 |
Variants in MBD5
This is a list of pathogenic ClinVar variants found in the MBD5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-148021034-A-G | not specified | Likely benign (Sep 29, 2016) | ||
2-148021035-G-A | not specified | Likely benign (Feb 10, 2017) | ||
2-148021062-C-T | not specified | Likely benign (Oct 16, 2015) | ||
2-148021483-GCTGCTGCTGCTGCTA-G | Likely benign (Feb 01, 2024) | |||
2-148021483-G-GCTGCTGCTGCTGCTA | Likely benign (Dec 01, 2023) | |||
2-148021496-C-CTGT | Likely benign (May 01, 2024) | |||
2-148021676-G-A | Likely benign (Feb 21, 2019) | |||
2-148021702-G-A | not specified | Likely benign (Jun 06, 2016) | ||
2-148178611-A-C | Benign (Jun 23, 2018) | |||
2-148178697-T-C | Likely benign (May 02, 2018) | |||
2-148178801-G-GT | Intellectual Disability, Dominant • not specified | Conflicting classifications of pathogenicity (Nov 01, 2022) | ||
2-148233246-A-G | Benign (Mar 03, 2015) | |||
2-148233249-A-G | not specified | Likely benign (Aug 02, 2017) | ||
2-148233382-A-G | not specified | Likely benign (Oct 28, 2016) | ||
2-148342230-C-T | not specified | Likely benign (Sep 01, 2017) | ||
2-148342233-A-C | not specified | Likely benign (Jan 23, 2017) | ||
2-148342233-A-T | Benign (Mar 03, 2015) | |||
2-148342300-C-CA | Intellectual Disability, Dominant | Uncertain significance (Jun 14, 2016) | ||
2-148342342-C-A | not specified | Likely benign (Sep 07, 2017) | ||
2-148342440-G-A | Likely benign (Feb 08, 2022) | |||
2-148342533-A-T | Benign (Jun 23, 2018) | |||
2-148342583-T-C | Benign (Jun 23, 2018) | |||
2-148458195-T-C | not specified | Benign (Aug 01, 2024) | ||
2-148458759-A-G | Intellectual disability, autosomal dominant 1 | Likely pathogenic (Oct 25, 2018) | ||
2-148458766-G-T | Intellectual disability, autosomal dominant 1 | Uncertain significance (Oct 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MBD5 | protein_coding | protein_coding | ENST00000407073 | 10 | 497226 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000141 | 125742 | 0 | 4 | 125746 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.856 | 710 | 777 | 0.914 | 0.0000403 | 9822 |
Missense in Polyphen | 35 | 42.073 | 0.83188 | 419 | ||
Synonymous | -0.611 | 301 | 288 | 1.05 | 0.0000161 | 3033 |
Loss of Function | 6.04 | 2 | 46.4 | 0.0431 | 0.00000244 | 595 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to heterochromatin. Does not interact with either methylated or unmethylated DNA (in vitro).;
- Disease
- DISEASE: Mental retardation, autosomal dominant 1 (MRD1) [MIM:156200]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:17847001, ECO:0000269|PubMed:22726846}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;UCH proteinases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.0958
Intolerance Scores
- loftool
- 0.0116
- rvis_EVS
- -2.12
- rvis_percentile_EVS
- 1.52
Haploinsufficiency Scores
- pHI
- 0.522
- hipred
- Y
- hipred_score
- 0.520
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.936
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mbd5
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- nervous system development;protein deubiquitination;regulation of multicellular organism growth;glucose homeostasis;regulation of behavior;positive regulation of growth hormone receptor signaling pathway
- Cellular component
- nucleus;nucleoplasm;chromocenter;midbody;extracellular exosome
- Molecular function
- DNA binding;chromatin binding